The Current Ratio as of November 2024 (TTM) for Virpax Pharmaceuticals, Inc. (VRPX) is 0.48

According to Virpax Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.48. This represents a change of -56.75% compared to the average of 1.11 of the last 4 quarters.

Virpax Pharmaceuticals, Inc. (VRPX) Historical Current Ratio (quarterly & annually)

How has VRPX Current Ratio performed in the past?

The mean historical Current Ratio of Virpax Pharmaceuticals, Inc. over the last ten years is 4.44. The current 0.48 Current Ratio has changed 983.09% with respect to the historical average. Over the past ten years (40 quarters), VRPX's Current Ratio was at its highest in in the September 2021 quarter at 23.88. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Virpax Pharmaceuticals, Inc. (VRPX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Virpax Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Virpax Pharmaceuticals, Inc. (VRPX) Average Current Ratio

How has VRPX Current Ratio performed in the past?

The current Current Ratio of Virpax Pharmaceuticals, Inc. (VRPX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Virpax Pharmaceuticals, Inc. (VRPX) Current Ratio vs. Peers

How is VRPX’s Current Ratio compared to its peers?

Virpax Pharmaceuticals, Inc.’s Current Ratio is greater than Panbela Therapeutics, Inc. (0.05), less than Revelation Biosciences, Inc. (1.10), less than Palisade Bio, Inc. (4.31), less than Virax Biolabs Group Limited (25.94), less than Quoin Pharmaceuticals, Ltd. (3.35), greater than ZIVO Bioscience, Inc. (0.17), less than RenovoRx, Inc. (4.39), less than Pasithea Therapeutics Corp. (6.20), less than ARCA biopharma, Inc. (26.61), less than Nutriband Inc. (6.57), less than Longeveron Inc. (4.18), less than Blue Water Vaccines, Inc. (0.54), less than Hillstream BioPharma, Inc. (2.25), less than Kiora Pharmaceuticals, Inc. (19.22), less than Biodexa Pharmaceuticals Plc (2.16), less than Praxis Precision Medicines, Inc. (17.30),

Build a custom stock screener for Virpax Pharmaceuticals, Inc. (VRPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virpax Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Virpax Pharmaceuticals, Inc. (VRPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Virpax Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.